US Stock MarketDetailed Quotes
LENZ LENZ Therapeutics
- 21.100
- +0.190+0.91%
Close Sep 17 16:00 ET
580.18MMarket Cap-6850P/E (TTM)
21.260High20.585Low112.04KVolume20.940Open20.910Pre Close2.36MTurnover0.90%Turnover RatioLossP/E (Static)27.50MShares25.77052wk High3.01P/B264.01MFloat Cap9.51352wk Low--Dividend TTM12.51MShs Float160.912Historical High--Div YieldTTM3.23%Amplitude7.525Historical Low21.057Avg Price1Lot Size
LENZ Therapeutics Key Stats
Quarterly+Annual
YOY
| (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (FY)Dec 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15M | 0 | 0 |
| Operating revenue | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --15M | --0 | --0 |
| Cost of revenue | ||||||||||
| Gross profit | ||||||||||
| Operating expense | -4.06%14.35M | 27.52%16.09M | 184.22%72.43M | 173.79%24.99M | 19.87M | 14.96M | 12.62M | 280.68%25.48M | 9.13M | 6.69M |
| Selling and administrative expenses | 219.27%7.41M | 142.30%5.55M | 196.58%12.93M | 264.26%5.45M | --2.86M | --2.32M | --2.29M | 76.15%4.36M | --1.5M | --2.47M |
| Research and development costs | -45.05%6.95M | 2.05%10.54M | 181.68%59.5M | 156.04%19.54M | --17M | --12.64M | --10.33M | 400.59%21.13M | --7.63M | --4.22M |
| Operating profit | 4.06%-14.35M | -27.52%-16.09M | -590.92%-72.43M | -173.79%-24.99M | -19.87M | -14.96M | -12.62M | -56.60%-10.48M | -9.13M | -6.69M |
| Net non-operating interest income expense | 881.27%2.46M | 788K | 2.19M | 251K | 0 | |||||
| Non-operating interest income | 881.27%2.46M | --788K | --2.19M | ---- | ---- | --251K | --0 | ---- | ---- | ---- |
| Other net income (expense) | 9,183.33%1.64M | -2,396.30%-1.35M | 389.47%93K | -107,200.00%-1.07M | 1.24M | -18K | -54K | 102.19%19K | 1K | -869K |
| Other non- operating income (expenses) | 9,183.33%1.64M | -2,396.30%-1.35M | 389.47%93K | -107,200.00%-1.07M | --1.24M | ---18K | ---54K | 102.19%19K | --1K | ---869K |
| Income before tax | 30.37%-10.25M | -31.40%-16.65M | -570.37%-70.15M | -161.57%-23.87M | -18.88M | -14.73M | -12.67M | -38.36%-10.46M | -9.13M | -7.56M |
| Income tax | -151.59%-179K | -159.08%-179K | 347K | 303K | 0 | |||||
| Net income | 30.37%-10.25M | -31.40%-16.65M | -547.19%-69.97M | -151.27%-23.69M | -18.88M | -14.73M | -12.67M | -42.95%-10.81M | -9.43M | -7.56M |
| Net income continuous Operations | 30.37%-10.25M | -31.40%-16.65M | -547.19%-69.97M | -151.27%-23.69M | ---18.88M | ---14.73M | ---12.67M | -42.95%-10.81M | ---9.43M | ---7.56M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 30.37%-10.25M | -31.40%-16.65M | -547.19%-69.97M | -151.27%-23.69M | -18.88M | -14.73M | -12.67M | -42.95%-10.81M | -9.43M | -7.56M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 30.37%-10.25M | -31.40%-16.65M | -547.19%-69.97M | -151.27%-23.69M | -18.88M | -14.73M | -12.67M | -42.95%-10.81M | -9.43M | -7.56M |
| Basic earnings per share | 30.64%-0.4 | -611.39%-3.53 | -547.19%-2.7402 | -151.27%-0.9279 | -0.7394 | -0.5767 | -0.4962 | -42.95%-0.4234 | -0.3693 | -0.2962 |
| Diluted earnings per share | 30.64%-0.4 | -611.39%-3.53 | -547.19%-2.7402 | -151.27%-0.9279 | -0.7394 | -0.5767 | -0.4962 | -42.95%-0.4234 | -0.3693 | -0.2962 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | -- | -- | -- | -- | Unqualified Opinion | -- | Unqualified Opinion |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data